/ /

  • linkedin
  • Increase Font
  • Sharebar

    Low-dose atropine for myopia in children: two years of experience

    Nightly treatment with atropine drops can significantly slow progression



    1.     Chua WH, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113:2285-2291.

    2.     Chia A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347-354.

    3.     Tong L, et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009;116:572-579.

    4.     Chia A, et al. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123:391-399.

    5.     Dayan YB, et al. The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Investig. Opthalmology Vis. Sci. 2005;46:2760.

    6.     Smith TST,  et al. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull. World Health Organ. 2009;87:431-437.

    7.     Cooke Bailey JN,  et al. Advances in the genomics of common eye diseases. Hum. Mol. Genet. 2013;22:R59-R65.

    8.     He M, et al. Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China: A Randomized Clinical Trial. JAMA. 2015;314:1142.

    9.     Huang HM, Chang D-ST , Wu P-C. The Association between Near Work Activities and Myopia in Children—A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0140419.


    Dr Professor Yair Morad, MD

    E: [email protected]

    Professor Morad works at Assaf Harofeh Medical Center, Tel Aviv University.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results